Desert Ridge Allergy Associates

05/19/2026

https://jamanetwork.com/journals/jama/fullarticle/2847972?guestAccessKey=825c3f95-36ef-4a6b-bd07-2b1b9efa9fa2&utm_source=fbpage&utm_medium=social_jama&utm_term=20515907451&utm_campaign=article_alert&linkId=944564150&fbclid=IwY2xjawR5setleHRuA2FlbQIxMABicmlkETFUNGdiSHZqMFVUN0p6UDhMc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHpVxijwXFDs1vXIrjAZFbMsb8BMJiIGFmp7zuA9i2mYcxy6dqoM43bjexT3e_aem_a-5HsaQpxIveDI2DC8p3TQ

This retrospective cohort study examines treatment failure and adverse events in standard-dose amoxicillin compared with amoxicillin-clavulanate in adults with acute sinusitis.

11/20/2025

https://www.aap.org/en/news-room/news-releases/aap/2025/statement-by-aap-president-susan-j.-kressly-md-faap-on-changes-to-cdcs-website-on-autism

“The Centers for Disease Control and Prevention website has been changed to promote false information suggesting vaccines cause autism. Since 1998, independent researchers across seven countries have conducted more than 40 high-quality studies involving over 5.6 million people. The conclusion is c...

04/19/2025

https://www.hcplive.com/view/fda-approves-dupilumab-dupixent-for-chronic-spontaneous-urticaria?fbclid=IwY2xjawJvyllleHRuA2FlbQIxMQABHu6wk2E4kbgGIfg-HaoZ1UuYpGtQd84pN2_-cpQfmAu1vSf7f2bmcbFebblI_aem_RwuSekeuAGW9JWAf5sBNsg

Dupilumab's approval marks the first new, targeted therapy for CSU in more than a decade and is the 7th indication for a disease with underlying type 2 inflammation.

04/13/2025

https://www.allergicliving.com/2025/04/11/xolair-rival-aims-for-food-allergy-dosing-of-every-2-to-3-months/

Rapt’s anti-IgE therapy RPT904 may prove a rival to Xolair for multiple . In an early study, only required shots 2–3 months.

10/30/2024

https://apple.news/A21W2FkisRCeemAM40kmLBg

"The system is really getting in the way," said a pediatric pulmonologist.

08/10/2024

https://l.facebook.com/l.php?u=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Ffda-approves-first-nasal-spray-treatment-anaphylaxis%3Ffbclid%3DIwZXh0bgNhZW0CMTEAAR1YKeDIl0GFoJWS5U--V-DB7b8RY6Z4hzYzqZ_V8mF6boiK6t7jLCLQjjE_aem_vRXwn1J5A0x7RX-3agsxHQ&h=AT1NRdw4gDPTSvzUaaP_MQbqCpPn6rQCksNDoemHjLqXDq4apDZxDanf7PnGSx0-omhq-bRC3QWflHHlLoNGG1rTvoIaXNDIjH8pwacBA1zvxcGRBdacpE3Z3AgLA2MuRsOsy0g&__tn__=H-R&c[0]=AT3k5wm98ZTKJh###yFvGjdrIVJ5AQHsqtM_BK6aI6_Y3X2RBN_xxjHX-Fs_yev_waCrFXapgPyK7GYomgSx-nmhQclC6G6-HUwo3j5TxRGIVfeOqqaqCtgXsZtdGEXLwvt6IJykn18t1x7UlEz8BiAwS-7yTP6vGN7x7bfo9p5zmNnLDkY41kVTpPxrpHdlvEo_KR0oxgBNRJpJ7Om5nDDBoS_GSileHxAS27ypCmFNE_pVEV4

The FDA approved the first nasal spray for the emergency treatment of allergic reactions in adult and certain pediatric patients.

12/26/2023

Just a reminder that the office is closed January 1 - 3, 2024. Normal hours resume January 4. Thank you. We wish you a healthy happy new year.

08/02/2022

New COVID Vaccine boosters expected in September. Stay tuned.

With the new shots on the way, federal officials have decided not to expand eligibility for second boosters of the existing vaccines for those under age 50 years this summer.

07/13/2022

https://www.businesswire.com/news/home/20220712005124/en/Astepro®-Allergy-First-and-Only-Steroid-Free-Antihistamine-Nasal-Spray-Now-Available-Over-the-Counter?fbclid=IwAR0_deyZuBlIc_yfDPutEMyqYyTzpNsn5oWe-yoQQa7PdnwAn19VBf_7qLQ

06/24/2022

We now have COVID vaccines in stock for adults and children from age 6 months